Understanding and targeting of Siglec receptors on different myeloid cell subtypes in cancerResearch Project | 01.11.2022 - 31.10.2024 No Description availableFundingUnderstanding and targeting of Siglec receptors on different myeloid cell subtypes in cancerOno Pharmaceutical, 11.2022-10.2024 (24) PI : Läubli, Heinz.Members (1) Heinz LäubliPrincipal InvestigatorResearch GroupsCellular Immunotherapy (Läubli) Läubli Lab
Understanding and targeting of Siglec receptors on different myeloid cell subtypes in cancerResearch Project | 01.11.2022 - 31.10.2024
FundingUnderstanding and targeting of Siglec receptors on different myeloid cell subtypes in cancerOno Pharmaceutical, 11.2022-10.2024 (24) PI : Läubli, Heinz.
Understanding and targeting of Siglec receptors on different myeloid cell subtypes in cancerOno Pharmaceutical, 11.2022-10.2024 (24) PI : Läubli, Heinz.